NPLATE
Google image searchProduct monograph
Active ingredient
romiplostim, 250 MCG/VIAL
DIN: 02322854
Dosage form(s): POWDER FOR SOLUTION
Route(s) of administration: SUBCUTANEOUS
Schedule: Prescription / Schedule D
Company: AMGEN CANADA INC
Date: 15-APR-2009
ATC:
- B02 — ANTIHEMORRHAGICS (ATC, ATC/DDD, )
- B02B — VITAMIN K AND OTHER HEMOSTATICS (ATC, ATC/DDD)
- B02BX — Other systemic hemostatics (ATC, ATC/DDD)
- B02BX04 — ROMIPLOSTIM (ATC/DDD)
Reference brand drug: Nplate
